Novo Nordisk stock tumbles as Ozempic maker sets out 2030 goals
Novo Nordisk stock tumbled on Monday as the weight-loss drug manufacturer failed to excite investors hoping for a turnaround.
Last updated: 2026-09-21 11:15:11 ET
Novo Nordisk stock tumbled on Monday as the weight-loss drug manufacturer failed to excite investors hoping for a turnaround.
People on medications for weight loss are buying less food, shrinking their portion sizes and purchasing smaller clothes. Businesses are trying to adj...
The Danish drug giant behind Ozempic is competing with Eli Lilly in the market for weight-loss drugs.
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE